Early Diagnostic Biomarkers of Sepsis for Patients with Acute-on-Chronic Liver Failure: A Multicenter Study

• Published in: Infectious diseases and therapy Vol. 10; no. 1; pp. 281 - 290
• Main Authors: Chen, Jun, Huang, Ze-Bing, Li, Hai, Zheng, Xin, Chen, Jin-Jun, Wang, Xian-Bo, Qian, Zhi-Ping, Liu, Xiao-Xiao, Fan, Xue-Gong, Hu, Xing-Wang, Liao, Cheng-Jin, Long, Li-Yuan, Huang, Yan
• Format: Journal Article
• Language: English
• Published: Cheshire Springer Healthcare 01.03.2021; Springer; Springer Nature B.V
• Subjects: Biological markers; Biomarkers; C-reactive protein; Care and treatment; Communications equipment; Comparative analysis; Diagnosis; Health aspects; Infection; Infectious Diseases; Internal Medicine; Liver failure; Medical diagnosis; Medical research; Medicine; Medicine & Public Health; Medicine, Experimental; Mortality; NCT; NCT02457637; Original Research; Prognosis; Sepsis; Acute-on-chronic liver failure; Sepsis; Early diagnosis; Presepsin; sTREM-1; Multicenter study
• ISSN: 2193-8229; 2193-6382
• DOI: 10.1007/s40121-020-00362-x

Introduction Sepsis is a complication in acute-on-chronic liver failure (ACLF) patients associated with high rates of mortality and morbidity. Early diagnosis of sepsis in ACLF patients can improve prognosis. This study aimed to explore potential effective biomarkers for the early diagnosis of sepsis in ACLF patients. Methods Ninety-four ACLF patients with sepsis were enrolled from 10 hospitals across China from January 2015 to June 2016 as well as 49 ACLF patients without infection from Xiangya Hospital. The first-day admission data and SOFA score and CLIF-SOFA score were collected. The differences of indicators between groups were compared with Kruskal-Wallis test. The receiver-operating characteristic (ROC) curve was analyzed to evaluate the diagnostic efficiency of the selected factors. Results Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1) and presepsin were significantly higher in ACLF-sepsis patients compared with ACLF patients with no infection ( P  < 0.001). sTREM-1 and presepsin presented higher diagnostic value in sepsis for ACLF patients compared with other biomarkers [white blood cells (WBC), procalcitonin (PCT) and C-reactive protein (CRP)]. Combining sTREM-1 or presepsin with the CLIF-SOFA score increased the diagnostic efficiency (AUC = 0.876 or AUC = 0.913, respectively). Conclusions sTREM-1 and presepsin are potential biomarkers for the early diagnosis of sepsis in ACLF patients. The combination of presepsin and the CLIF-SOFA score is a promising method for diagnosing sepsis in ACLF patients. Trial Registration ClinicalTrials.gov identifier, NCT02457637.